Form 4: Medicine Man Technologies Director Receives Stock Grant for Board Service

Paul Montalbano, a director at Medicine Man Technologies, received 32,012 shares of common stock as compensation for his board service.

Summary

• Paul Montalbano, a director of Medicine Man Technologies, Inc. (SHWZ), reported a transaction on March 29, 2024, where he acquired 32,012 shares of common stock.
• These shares were granted as compensation for his service on the board of directors.
• The shares were valued at $26,250, based on the closing price of the common stock on the OTCQX Best Market on March 28, 2024.
• Following this transaction, Montalbano directly owns 253,420 shares of Medicine Man Technologies.

Sentiment

Score: 6

Explanation: The document itself is neutral, reporting a standard transaction. The sentiment is slightly positive as it reflects compensation for a board member, aligning interests with shareholders.

Positives

• The stock grant aligns the director's interests with those of the shareholders.
• The director is incentivized to improve the company's performance.

Industry Context

Stock grants to board members are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize them to contribute to the company's success. This is especially common in growth-oriented sectors like the cannabis industry, where Medicine Man Technologies operates.

Comparison to Industry Standards

• Comparing Medicine Man Technologies' director compensation practices to industry peers like Curaleaf, Trulieve, and Green Thumb Industries would provide a better understanding of whether the stock grant is within the typical range.
• Analyzing the percentage of equity granted to directors relative to the company's market capitalization and revenue can also offer insights into the appropriateness of the compensation.

Stakeholder Impact

• The stock grant could have a slightly dilutive effect on existing shareholders.
• The grant incentivizes the director to act in the best interests of the shareholders.

Key Dates

Keywords

Medicine Man Technologies, SHWZ, Paul Montalbano, Director, Stock Grant, Form 4, Beneficial Ownership, Compensation, Board Service